[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100427295":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Acute myocarditis",null,"Patients hospitalized for an acute myocarditis.",[13],{"name":14,"affiliation":15,"role":16},"Giles MONTALESCOT, MD, PhD","ACTION Study Group - Assistance Publique - Hôpitaux de Paris","STUDY_DIRECTOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Mathieu Kerneis, MD","CONTACT","+33142163001","mathieu.kerneis@aphp.fr",[24],{"facility":25,"status":26,"city":27,"state":10,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Hôpital Pitié-Salpêtrière","RECRUITING","Paris","75013","France","FR",{"type":32,"coordinates":33},"Point",[34,35],2.3488,48.85341,{"lat":35,"lon":34},[38],{"name":39,"role":20,"phone":40,"phoneExt":10,"email":22},"Mathieu KERNEIS, MD","0142163001",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100427295","acute-myocarditis-registry-with-prognostic-histologic-immunologic-biological-imaging-and-clinical-assessment-100427295",false,"NCT04844151","Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment","AMPHIBIA","Inclusion Criteria:\n\n* Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.\n* affiliation to the French Health Care System \"Sécurité sociale\"\n\nExclusion Criteria:\n\n* Severe valvulopathy\n* Complex congenital cardiopathy\n* Previous heart transplant\n* Known significative coronary disease","ALL","15 Years",{"count":53,"type":54},1400,"ESTIMATED","20 Years","OBSERVATIONAL","The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.",[59],"Myocarditis",[61,62,63,64],"Cardiomyopathies","Inflammatory heart disease","Magnetic resonance imaging","Viral","2025-06-03",{"date":67,"type":68},"2025-06-06","ACTUAL",{"date":70,"type":68},"2022-01-23",{"date":72,"type":54},"2041-05-01",{"name":5,"class":6},1]